CoChat

Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway

Ikebe, Mio, Kitaura, Yoshiki, Nakamura, Masafumi, Tanaka, Haruo, Yamasaki, Akio, Nagai, Shuntaro, Wada, Junji, Yanai, Kosuke, Koga, Kenichiro, Sato, Norihiro, Kubo, Makoto, Tanaka, Masao, Onishi, Hideya, Katano, Mitsuo · 2009 · Journal of Surgical Oncology
Cited by 172

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Inflammation plays a multifaceted role in cancer progression, and NF‐κB is one of the key factors connecting inflammation with cancer progression. We have shown that lipopolysaccharide (LPS) promotes NF‐κB activation in colon cancer cells and pancreatic cancer cells. However, it is unclear why inflammatory stimuli can induce NF‐κB activation in cancer cells. Methods: We used two human pancreatic cancer cells, Panc‐1 and AsPC‐1, as target cells. LPS was used as an inflammatory stimulus. To confirm the participation of TLR4/NF‐κB signaling pathway, we used three different NF‐κB inhibitors (PDTC, IκBα mutant, and NF‐κB decoy ODN) and siRNAs (against TLR4, MyD88, and MMP‐9). Effect of LPS on pancreatic cancer cell invasive ability was determined by Matrigel invasion assay. Results: LPS increased the invasive ability of pancreatic cancer cells, while blockade of NF‐κB pathway decreased the LPS‐dependent increased invasive ability. Blockade of TLR4 or MyD88 by siRNA also decreased the LPS‐dependent increased invasive ability. Conclusion: These results suggest that TLR/MyD88/NF‐κB signaling pathway plays a significant role in connecting inflammation and cancer invasion and progression. J. Surg. Oncol. 2009;100:725–731. © 2009 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jso.21392

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 172

Metadata

Authors
Ikebe, M., Kitaura, Y., Nakamura, M., Tanaka, H., Yamasaki, A., Nagai, S., Wada, J., Yanai, K., Koga, K., Sato, N., Kubo, M., Tanaka, M., Onishi, H., & Katano, M.
Venue
Journal of Surgical Oncology
Publisher
Wiley
Published
2009-08-31
Volume
100
Issue
8
Pages
725-731
ISSN
  • 0022-4790 (ISSN-L)
  • 1096-9098
OpenAlex
W2054683516
Cited by
172
References
5
FWCI
2.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. https://app.cochat.ai/papers/10.1002/jso.21392
The paper
Ikebe, M., Kitaura, Y., Nakamura, M., Tanaka, H., Yamasaki, A., Nagai, S., Wada, J., Yanai, K., Koga, K., Sato, N., Kubo, M., Tanaka, M., Onishi, H., & Katano, M. (2009). Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. Journal of Surgical Oncology. https://doi.org/10.1002/jso.21392

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.